Explore groundbreaking health trends from exosome treatments and HIV prevention injections to new obesity pills and brain implants. What do experts really think? Dive into the latest in health innovation and skepticism.
The FDA has approved lenacapavir, a groundbreaking antiviral drug for HIV prevention developed by biochemist Wesley Sundquist. Learn how this drug could change the future of HIV treatment and prevention.
A groundbreaking HIV prevention shot, Yeztugo, has been approved by the FDA, offering hope for at-risk individuals with its twice-yearly injections. However, concerns about cost and accessibility remain.
The FDA has approved Gilead's Yeztugo, a twice-yearly injection that could revolutionize HIV prevention, boasting a 99.9% effectiveness. While hailed as a breakthrough, concerns over pricing remain, with activists urging for affordability.
The U.S. has approved a groundbreaking twice-a-year shot, lenacapvir, for HIV prevention, potentially transforming care. Experts suggest this could significantly reduce new infections.
Health Secretary Robert F. Kennedy Jr. faces significant hurdles as Congress pushes back against his ambitious health reorganization plan, threatening the future of the Administration for a Healthy America.
The Trump administration's sudden cancellation of a $258 million HIV vaccine research program has ignited outrage among scientists and public health advocates, jeopardizing years of progress in HIV prevention and treatment as infection rates surge.
Today, the U.S. Supreme Court hears a pivotal case on Obamacare's preventive care mandate, with major implications for health coverage, including HIV prevention drugs like PrEP. Conservative employers argue the mandate is unconstitutional, raising fears about the future of essential health services.
A new study reveals that cuts in foreign aid by Western nations could lead to over 10 million new HIV infections and nearly 3 million deaths by the decade's end, particularly affecting vulnerable populations.
In a surprising turn, the Trump administration has terminated key funding for HIV programs aimed at adolescents, raising concerns over the future of HIV prevention efforts in the U.S.
